📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
232 analysed today
FollowTelegram
232
Today
149,633
All-time analysed
42,906
Positive
6,661
Negative
91,389
Neutral
8,609
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
96 announcements match the current filters (relevance ≥ 5).
Meghmani Organics Shareholders Meet to Approve Merger of Two Wholly Owned Subsidiaries
Meghmani Organics Limited (MOL) conducted an NCLT-convened meeting on June 06, 2026, to obtain shareholder approval for the amalgamation of Kilburn Chemicals Limited and Meghmani Crop Nutrition Limited into the parent company. Both entities are wholly owned subsidiaries, and the merger is designed to simplify the group structure into a single listed entity. The management expects this move to drive operational synergies, reduce administrative costs, and eliminate duplicate regulatory compliances. Voting results for the special resolution are expected to be declared by June 09, 2026.
Key Highlights
NCLT-convened meeting held on June 06, 2026, to approve the Scheme of Amalgamation.
Kilburn Chemicals and Meghmani Crop Nutrition (wholly owned subsidiaries) to be merged into Meghmani Organics.
The merger aims to consolidate operations into a single legal entity to unlock long-term value and financial synergies.
The scheme is expected to eliminate duplicate compliances and rationalize administrative costs.
Final voting results to be disseminated to stock exchanges on or before June 09, 2026.
👀 What to Watch
Investors should view this as a positive structural consolidation that streamlines operations; monitor the formal announcement of voting results on June 09, 2026, to confirm the merger's progression.
Meghmani Organics FY26: Standalone EBITDA Grows 27% to ₹228.7 Cr; TiO2 Operations Suspended
Meghmani Organics Limited (MOL) reported a 4% YoY increase in standalone revenue to ₹2,091 crores for FY26, while standalone EBITDA rose 27% to ₹228.7 crores. The company faced significant headwinds in Q4 FY26 due to US tariffs and geopolitical tensions, leading to the temporary suspension of its Titanium Dioxide (TiO2) plant due to commercial unviability. To drive future growth, MOL has established a 100% subsidiary in Brazil and received approvals for Nano DAP and Nano NPK fertilizers. The company is also undergoing a structural consolidation by merging its subsidiaries, Kilburn Chemicals and Meghmani Crop Nutrition, into the parent entity.
Key Highlights
FY26 consolidated revenue stood at ₹2,174 crores with an EBITDA margin of 8.1% compared to 6.9% YoY.
Crop Protection segment contributed 78% of revenue with a 15% EBITDA margin, while Pigments utilization remained low at 40%.
Titanium Dioxide operations suspended due to high sulphuric acid costs and the withdrawal of anti-dumping duties.
Consolidated debt stands at ₹722 crores after a repayment of ₹160 crores during the financial year.
Received Ministry approval for Nano DAP, Nano NPK, and Nano Zinc with commercial production starting Kharif FY27.
👀 What to Watch
Investors should monitor the DGTR's decision on anti-dumping duties for TiO2 and the ramp-up of the high-margin Nano fertilizer segment. While the Brazil expansion is a long-term positive, the current pressure on margins due to geopolitical risks warrants a cautious outlook.
Mold-Tek Tech Q4 PAT Hits ₹2.28 Cr; Strategic Pivot to High-Margin Structural Design
Mold-Tek Technologies reported a turnaround in Q4 FY26 with a PAT of ₹2.28 crores, overcoming a ₹4 crore MTM loss from rupee depreciation. The company is strategically downsizing its loss-making BIW auto sector team from 160 to 60 members to eliminate a ₹7 crore annual loss drag. Growth is currently driven by the Civil Structural Division, where work on hand rose to $5 million, and the successful integration of the Beryl acquisition in the US. Management is shifting focus toward high-value structural design services which command hourly rates of $70-$80 compared to $25-$30 for traditional detailing.
Key Highlights
Q4 PAT turned positive at ₹2.28 crores vs a loss of ₹1.62 crores in the previous year's quarter.
Civil work order book increased 25% to $5 million from $4 million at the start of the year.
Strategic downsizing of BIW auto team from 160 to 60 to stop a ₹7 crore annual profitability leak.
Expansion into high-margin structural design services commanding $70-$80/hour rates.
Beryl acquisition (Nov 2025) integrated, contributing 5 months of revenue to the US residential design segment.
👀 What to Watch
Investors should view the strategic downsizing of the bleeding BIW segment and the pivot to high-margin design services as a long-term margin catalyst. Monitor the execution of the $5 million civil order book and the continued integration of Beryl for sustained growth in FY27.
Anmol India FY26 Results: Total Equity Grows to ₹118.96 Cr; Receivables Rise to ₹91.96 Cr
Anmol India Limited reported its audited standalone financial results for the fiscal year ended March 31, 2026. The company's total equity improved to ₹118.96 crore from ₹107.47 crore in the previous year, indicating steady internal accruals. However, total assets saw a marginal decline to ₹344.19 crore from ₹358.84 crore. A key point of observation is the 27.6% increase in trade receivables, while cash and cash equivalents remained robust at ₹127.07 crore.
Key Highlights
Total Equity increased by 10.7% year-on-year to ₹118.96 crore
Trade Receivables rose significantly to ₹91.96 crore from ₹72.06 crore
Inventories decreased to ₹75.84 crore from ₹94.73 crore in the previous year
Cash and cash equivalents stood at ₹127.07 crore as of March 31, 2026
Non-current borrowings remained stable at ₹40.81 crore
👀 What to Watch
Investors should monitor the company's ability to convert its rising trade receivables into cash. The reduction in inventory and healthy cash position are positive signs of working capital management, but the slight contraction in total assets warrants a closer look at revenue growth.
Mold-Tek Packaging Q4 FY26: Pharma Segment Surges 200% as Full-Year Sales Grow 13.4%
Mold-Tek Packaging reported a healthy 13.4% sales growth for FY26, driven by a massive 200% surge in the Pharma packaging segment which reached ₹34.4 crores. The company is pivoting towards high-margin segments, with Pharma targets set at ₹50-₹55 crores for FY27 and a planned reduction in capex to ₹80-₹85 crores. While the Lubricants segment saw a decline due to the loss of the BPCL contract, strong recoveries in Paints and Food/FMCG offset the impact. Management expects capacity to reach nearly 70,000 MTPA by FY27, focusing on brownfield expansions to improve utilization and margins.
Key Highlights
Pharma packaging segment grew by over 200% in FY26, contributing ₹34.4 crores to total revenue.
Overall sales growth stood at 13.4% for the year, supported by a 17% Q4 growth in the Asian Paints account.
Planned capex for FY27 reduced to ₹80-₹85 crores from ₹120 crores, focusing on brownfield expansion.
Capacity utilization currently stands at approximately 68% with 43,000 tons utilized out of 63,000 MTPA.
Grasim (Aditya Birla Group) volumes grew 60% YoY, becoming a top 10 customer for the company.
👀 What to Watch
Investors should favor the stock's shift toward high-margin Pharma and FMCG segments which are de-risking the portfolio from the volatile Lubricants business. Monitor the execution of brownfield expansions at Mysore and Satara for margin expansion.
Mold-Tek Packaging FY26 PAT Rises 20.35% to ₹72.87 Cr; EBITDA Up 20.59%
Mold-Tek Packaging Limited reported a robust financial performance for the fiscal year ended March 31, 2026, with a 20.35% increase in Profit After Tax (PAT) to ₹72.87 crore. Annual revenue grew by 13.48% to ₹886.61 crore, supported by an 11.39% growth in sales volumes across key segments. The company demonstrated strong operational efficiency, with EBITDA growing by 20.59% year-on-year. For the fourth quarter alone, PAT surged by approximately 26.8% compared to the same period last year, indicating accelerating momentum.
Key Highlights
Annual Revenue increased by 13.48% YoY to ₹886.61 crore in FY26.
Net Profit (PAT) for the full year rose by 20.35% to ₹72.87 crore from ₹60.55 crore.
Sales volumes grew by 11.39% driven by strong demand across key business segments.
EBITDA growth of 20.59% reflects significant improvement in operational performance.
Q4 FY26 Revenue stood at ₹237.86 crore, representing a 17.4% increase over Q4 FY25.
👀 What to Watch
The strong double-digit growth in both revenue and profitability suggests healthy demand and operational efficiency. Investors may consider this a positive signal for long-term growth in the rigid packaging sector.
Meghmani Organics Q4 Net Profit Drops 42% to ₹19.5 Cr; FY26 Full Year PAT Surges 89%
Meghmani Organics reported a challenging Q4 FY26 with revenue declining 9% YoY to ₹456.6 crore and EBITDA margins shrinking to 5.7% from 12.9% due to export headwinds and rising costs. Despite the weak quarter, the full-year FY26 performance was robust, with Net Profit rising 89% YoY to ₹125.3 crore. The company is facing significant pressure in its Pigments segment (40% utilization) and has suspended its Titanium Dioxide (TiO2) operations due to commercial unviability. Management is now focusing on new Nano fertilizer products to drive future growth.
Key Highlights
Q4 FY26 EBITDA fell 59% YoY to ₹26.2 crore with margins contracting by 720 bps to 5.7%.
Full-year FY26 Revenue grew 4% to ₹2,091.8 crore, while Net Profit jumped 89% to ₹125.3 crore.
Crop Protection segment remains the primary driver, contributing 78% of FY26 revenue with 14.9% EBITDA margins.
Pigments segment utilization stood at a low 40% for FY26 with a thin EBITDA margin of 3.3%.
Operations for Titanium Dioxide (TiO2) have been temporarily suspended due to high raw material costs and withdrawal of anti-dumping duties.
👀 What to Watch
Investors should monitor the impact of US tariffs and geopolitical headwinds on export volumes, which significantly hurt Q4 margins. While the full-year growth is positive, the suspension of TiO2 operations and low Pigment utilization suggest near-term volatility; wait for signs of margin stabilization.
Meghmani Organics FY26: Crop Protection Revenue Hits ₹1,631 Cr; Diversifies into Nano Urea
Meghmani Organics (MOL) reported a growth in its Crop Protection segment, reaching ₹1,631 Crore in FY26, up from ₹1,451 Crore in FY25, driven by strong export demand (87%). However, the Pigments segment faced headwinds, with revenue declining to ₹461 Crore and capacity utilization dropping to 40%. The company is aggressively diversifying into high-margin areas, including Titanium Dioxide (TiO2) through the acquisition of Kilburn Chemicals and a new Nano Urea plant with a 5-crore bottle annual capacity. Strategic expansions are underway, including a new subsidiary in Brazil to capture the Latin American market.
Key Highlights
Crop Protection revenue grew 12.4% YoY to ₹1,631 Crore, maintaining a high export share of 87%.
Pigments segment revenue fell to ₹461 Crore in FY26 from ₹553 Crore in FY25, with utilization at 40%.
Commissioned a Nano Urea Liquid Fertilizer plant at Sanand with a massive 5 Crore bottle annual capacity.
Targeting import substitution in the TiO2 market, where 79% of India's 4,85,000 MTPA demand is currently imported.
Expanded global reach to 75+ countries with 45% of Crop Protection demand coming from the US and Brazil.
👀 What to Watch
Investors should monitor the volume ramp-up in the new Nano Urea and TiO2 segments to see if they can offset the current margin pressure in the Pigments business. The company's focus on 'China Plus One' and import substitution makes it a long-term recovery play in the specialty chemicals space.
Mold-Tek Tech Q4 Standalone Revenue Jumps 61% YoY; FY26 Net Profit at ₹10.58 Cr
Mold-Tek Technologies reported a strong recovery in Q4 FY26 with standalone revenue reaching ₹40.18 crore, a 61.7% increase from ₹24.84 crore in the same quarter last year. The company achieved a turnaround in Q4 with a net profit of ₹3.22 crore compared to a loss of ₹1.61 crore in Q4 FY25. On a full-year basis, standalone revenue grew 10.7% to ₹142.81 crore, though net profit saw a slight decline from ₹11.89 crore to ₹10.58 crore due to higher operating costs. Total comprehensive income for the year improved significantly to ₹11.87 crore, supported by fair value gains.
Key Highlights
Standalone Q4 revenue surged 61.7% YoY to ₹4,017.88 lakhs compared to ₹2,484.17 lakhs.
Q4 Net Profit turned positive at ₹322.37 lakhs versus a loss of ₹161.34 lakhs in the previous year's quarter.
Full-year FY26 standalone revenue grew 10.7% to ₹14,280.83 lakhs.
Annual standalone net profit dipped 11% to ₹1,058.35 lakhs, impacted by a significant rise in 'Other Expenses' to ₹2,904.71 lakhs.
Total Comprehensive Income for FY26 more than doubled to ₹1,187.05 lakhs from ₹531.36 lakhs in FY25.
👀 What to Watch
Investors should take note of the strong revenue momentum and the successful turnaround in the final quarter. While annual margins were pressured by rising costs, the sharp recovery in Q4 suggests improving operational efficiency heading into the next fiscal year.
Mold-Tek Tech Q4 Revenue Surges 61% YoY; FY26 Net Profit at ₹10.58 Crore
Mold-Tek Technologies reported a strong Q4 FY26 performance with revenue jumping 61.7% YoY to ₹40.18 crore. The company achieved a significant turnaround in the quarter, posting a net profit of ₹3.22 crore compared to a loss of ₹1.61 crore in the year-ago period. For the full year FY26, revenue grew 10.7% to ₹142.81 crore, though net profit dipped slightly to ₹10.58 crore from ₹11.89 crore due to higher operating expenses. Total comprehensive income for the year saw a substantial boost, reaching ₹11.87 crore compared to ₹5.31 crore in FY25.
Key Highlights
Q4 FY26 revenue from operations increased to ₹4,017.88 lakhs from ₹2,484.17 lakhs YoY.
Turned around Q4 bottom line with a profit of ₹322.37 lakhs against a loss of ₹161.34 lakhs in Q4 FY25.
Full-year FY26 revenue grew to ₹14,280.83 lakhs, representing a 10.7% growth over FY25.
Annual EPS for FY26 stood at ₹3.68, compared to ₹4.16 in the previous financial year.
Total Comprehensive Income for FY26 surged to ₹1,187.05 lakhs from ₹531.36 lakhs in FY25.
👀 What to Watch
The strong Q4 turnaround and revenue momentum are positive signals for the company's growth trajectory. Investors should monitor if the company can maintain these improved margins in the coming quarters despite rising employee costs.
Mold-Tek Technologies Q4 FY26 Revenue Jumps 61.7% YoY; Annual Profit at ₹10.58 Crore
Mold-Tek Technologies reported a strong recovery in Q4 FY26 with revenue growing 61.7% YoY to ₹40.18 crore and turning profitable compared to a loss in the same quarter last year. However, on a full-year basis, net profit saw a decline of 11% to ₹10.58 crore from ₹11.89 crore in FY25, primarily due to a significant rise in other expenses which nearly doubled. The company maintained a healthy revenue growth of 10.7% for the full year FY26. Despite the annual profit dip, the quarterly turnaround indicates positive momentum heading into the next fiscal year.
Key Highlights
Q4 FY26 Revenue from operations surged 61.7% YoY to ₹4,017.88 lakhs compared to ₹2,484.17 lakhs.
Net Profit for Q4 FY26 stood at ₹322.37 lakhs, recovering from a loss of ₹161.34 lakhs in Q4 FY25.
Full-year FY26 Revenue grew 10.7% to ₹14,280.83 lakhs compared to ₹12,899.83 lakhs in FY25.
Annual Net Profit declined by 11% to ₹1,058.35 lakhs, impacted by a sharp rise in other expenses to ₹2,904.71 lakhs.
Earnings Per Share (EPS) for the full year decreased to ₹3.68 from ₹4.16 in the previous year.
👀 What to Watch
Investors should focus on the strong quarterly revenue growth and the turnaround from losses, while monitoring the management's control over rising operating expenses. The stock remains a watch for sustained margin improvement in the coming quarters.
Meghmani Organics FY26 Net Profit Jumps 88% to ₹125 Cr; Agrochemicals Drive Growth
Meghmani Organics Limited (MOL) reported a robust 88.6% YoY increase in standalone net profit for FY26, reaching ₹125.26 crore. While annual revenue grew moderately by 4.4% to ₹2,091.81 crore, the Agrochemicals division was the primary growth engine, offsetting a 16.7% decline in the Pigments segment. The fourth quarter (Q4 FY26) showed some pressure with a 42% YoY drop in PAT, but the overall annual EPS improved significantly to ₹4.93 from ₹2.61. The company also announced a strategic amalgamation of its subsidiaries to simplify its group structure.
Key Highlights
FY26 Standalone Net Profit surged 88.6% YoY to ₹125.26 crore compared to ₹66.42 crore in FY25.
Agrochemicals segment revenue grew 12.4% to ₹1,631.24 crore, while Pigments revenue fell 16.7% to ₹460.57 crore.
Full-year Earnings Per Share (EPS) rose significantly to ₹4.93 from ₹2.61 in the previous fiscal year.
Board approved the merger of Kilburn Chemicals and Meghmani Crop Nutrition into the parent company for operational synergy.
The company invested in a 3.30 MW Wind Solar Hybrid Power plant to secure long-term renewable energy supply.
👀 What to Watch
Investors should view the strong annual profit growth and subsidiary consolidation as positive long-term indicators despite the weak Q4 performance. Monitor the Agrochemicals segment's margin sustainability and the execution of the proposed amalgamation.
Mold-Tek Packaging Reports Strong FY26 Performance with 20% PAT Growth to ₹72.87 Cr
Mold-Tek Packaging delivered a robust financial performance for FY26, with revenue growing 13.48% to ₹886.60 crore and PAT increasing 20.35% to ₹72.87 crore. The company achieved significant margin improvement, with EBITDA per KG rising 8% to ₹40.74, driven by plant consolidation and a shift towards high-margin segments like Pharma and Food & FMCG. The Pharma segment was a standout performer, recording 220% growth during the year. Operational efficiency was further bolstered by backward integration in label making and the implementation of AI-based inspection systems.
Key Highlights
FY26 Revenue grew 13.48% YoY to ₹886.60 crore, while Q4 revenue rose 17.40% to ₹237.86 crore.
Annual PAT increased by 20.35% to ₹72.87 crore, with Q4 PAT showing a stronger growth of 26.88% YoY.
EBITDA per KG improved from ₹37.60 to ₹40.74, reflecting better product mix and cost controls.
The Pharma segment achieved 220% growth in FY26, while the Food & FMCG segment grew by 15%.
Total sales volume for the full year reached 42,628 MT, marking an 11.41% increase over the previous year.
👀 What to Watch
Investors should note the successful margin expansion and the rapid growth in high-value segments like Pharma and Food. The company's focus on innovation, such as AI-based automation and new IP-based caps, positions it well for continued premiumization.
Mold-Tek Packaging FY26 PAT Up 20% to ₹72.87 Cr; Pharma Segment Grows 209%
Mold-Tek Packaging reported a strong FY26 with a 20.35% increase in Net Profit to ₹72.87 Cr and a 13.44% rise in revenue to ₹886.61 Cr. The Pharma Packaging segment was the standout performer, recording an exceptional volume growth of 208.96%, while the FMCG and Paint segments also saw healthy growth. The company successfully consolidated its Hyderabad operations from five units to two, which is expected to improve margins from FY27 onwards. Management has guided for a turnover exceeding ₹1,000 Cr in FY27, supported by new capacities for the Aditya Birla Group.
Key Highlights
FY26 Revenue grew 13.44% YoY to ₹886.61 Cr, with EBITDA per kg improving to ₹40.74.
Pharma segment volume surged 208.96% YoY, achieving the projected turnover of ₹35 Cr.
Q4 FY26 Net Profit rose 26.88% YoY to ₹20.64 Cr, driven by a 17.37% increase in sales volume.
Management guides for ₹1,000 Cr+ revenue in FY27, aided by the new Mahad plant for Grasim Industries.
Operational efficiency improved via consolidation of Hyderabad units from 5 to 2, with full benefits expected in FY27.
👀 What to Watch
Investors should focus on the high-margin Pharma segment's rapid growth and the upcoming ₹1,000 Cr revenue milestone as key re-rating triggers. The consolidation of units and new capacity for Grasim suggest strong earnings visibility and margin expansion potential for FY27.
Meghmani Organics to Hold Unsecured Creditors Meeting on June 6 for Amalgamation Scheme
Meghmani Organics Limited (MOL) has scheduled an NCLT-convened meeting for its unsecured creditors on June 6, 2026, to seek approval for a Scheme of Amalgamation. The scheme involves merging Kilburn Chemicals Limited and Meghmani Crop Nutrition Limited into Meghmani Organics. This procedural step follows NCLT orders from April 2026 and is a critical milestone in the company's consolidation strategy. The voting eligibility was determined based on a cut-off date of March 27, 2026.
Key Highlights
Meeting of unsecured creditors scheduled for June 6, 2026, at 3:30 p.m. IST via video conferencing.
Proposed merger involves two entities, Kilburn Chemicals and Meghmani Crop Nutrition, into Meghmani Organics.
Remote e-voting period is set from June 3, 2026, to June 5, 2026.
The cut-off date for determining voting eligibility was fixed as March 27, 2026.
The scheme is subject to approval by the requisite majority of creditors and final sanction by the NCLT Ahmedabad Bench.
👀 What to Watch
Investors should monitor the outcome of the creditors' meeting as it is a key regulatory hurdle for the merger. Successful consolidation is expected to streamline operations and potentially improve financial synergies.
Meghmani Organics Schedules June 6 Meeting for Amalgamation of Kilburn and Meghmani Crop Nutrition
Meghmani Organics Limited (MOL) is progressing with its corporate restructuring by convening an NCLT-directed meeting of secured creditors on June 6, 2026. The meeting is intended to seek approval for the Scheme of Amalgamation of Kilburn Chemicals Limited and Meghmani Crop Nutrition Limited into Meghmani Organics. The eligibility cut-off date for voting was set for March 27, 2026, with the remote e-voting window open from June 3 to June 5, 2026. This consolidation is expected to streamline operations and integrate the group's chemical and crop nutrition segments.
Key Highlights
Proposed merger of Kilburn Chemicals and Meghmani Crop Nutrition into Meghmani Organics Limited.
NCLT-convened secured creditors' meeting scheduled for June 6, 2026, at 3:00 PM via Video Conferencing.
Cut-off date for determining voting eligibility is March 27, 2026.
Remote e-voting period spans from June 3, 2026 (9:00 AM) to June 5, 2026 (5:00 PM).
The scheme remains subject to approval by the requisite majority of creditors and final NCLT sanction.
👀 What to Watch
Investors should monitor the outcome of the June 6 meeting as the merger will consolidate the company's business units, potentially leading to better operational synergies. No immediate action is required, but the consolidation is generally a positive long-term structural move.
Meghmani Organics Gets Govt Approval for Nano DAP, NPK & Zinc; Production to Start in Kharif 2026
Meghmani Organics' subsidiary, MCNL, has received Ministry of Agriculture approval to manufacture Nano DAP, Nano NPK, and Nano Zinc. The production will be housed at the Sanand facility in Gujarat, leveraging existing infrastructure with zero additional capital expenditure. Commercial production is scheduled to begin in the 2026 Kharif season, marking a strategic entry into the high-growth nano-fertilizer segment. This move allows the company to diversify its portfolio beyond its core pesticide and pigment businesses using its 3,500+ dealer network.
Key Highlights
Received Ministry approval for manufacturing Nano DAP, Nano NPK, and Nano Zinc fertilizers.
Zero additional CAPEX required as production will utilize existing infrastructure at the Sanand facility.
Commercial production is expected to commence during the 2026 Kharif season.
Leverages a massive distribution network of 3,500+ distributors and dealers across India.
Meghmani Organics currently generates approximately 85% of its topline from export markets as of FY25.
👀 What to Watch
Investors should monitor the successful rollout and market adoption of these nano-products during the Kharif season, as the zero-capex entry provides a high-margin growth opportunity. This diversification could reduce the company's heavy reliance on the volatile global pesticide market.
Meghmani Organics to Hold NCLT-Convened Meeting on June 6, 2026 for Merger Approval
Meghmani Organics Limited (MOL) has scheduled an NCLT-convened meeting on June 6, 2026, to seek shareholder approval for the merger of Kilburn Chemicals and Meghmani Crop Nutrition into itself. The proposed scheme involves the amalgamation of two 100% promoter-owned entities into the listed parent. Importantly, the post-merger shareholding pattern of MOL will remain unchanged, with promoters at 48.95% and the public at 51.05%. This consolidation is a structural move to streamline group operations under a single entity.
Key Highlights
NCLT-convened meeting for equity shareholders scheduled for June 6, 2026, at 2:00 PM IST.
Amalgamation of Kilburn Chemicals and Meghmani Crop Nutrition into Meghmani Organics Limited.
No change in shareholding pattern post-merger; Public holding remains at 51.05% and Promoters at 48.95%.
Remote e-voting period is set from June 3 to June 5, 2026, with a cut-off date of May 30, 2026.
All paid-up equity shares of the transferor companies will be cancelled upon the scheme's implementation.
👀 What to Watch
Investors should note that this is an internal consolidation with no equity dilution; they are advised to vote in favor of the resolution to support operational streamlining.
Meghmani Organics Corrects Amalgamation Meeting Schedule to June 6, 2026
Meghmani Organics Limited (MOL) has issued a correction regarding the schedule of meetings for its proposed Scheme of Amalgamation involving Kilburn Chemicals and Meghmani Crop Nutrition. The meetings for equity shareholders, secured creditors, and unsecured creditors of MOL are now confirmed for June 06, 2026, via video conferencing. This update rectifies a typographical error in the company's previous communication dated May 1, 2026. The schedules for the transferor companies remain unchanged as per the original plan.
Key Highlights
Equity Shareholders meeting scheduled for June 06, 2026, at 2:00 PM IST via Video Conferencing
Secured Creditors meeting set for June 06, 2026, at 3:00 PM IST
Unsecured Creditors meeting set for June 06, 2026, at 3:30 PM IST
Amalgamation involves Kilburn Chemicals Limited and Meghmani Crop Nutrition Limited as transferor companies
Correction follows directions from the Hon’ble NCLT regarding the Transferee Company
👀 What to Watch
Investors should mark June 6, 2026, as the key date for the shareholder vote on the merger. Monitor for the upcoming explanatory statement and notice for further details on the amalgamation terms.
Mold-Tek Technologies Cancels Preferential Issue of 2.90 Lakh Shares Due to Non-Payment
Mold-Tek Technologies Limited has officially withdrawn its proposed preferential issue of 2,90,000 equity shares. The shares were priced at ₹164 each (including a ₹162 premium), which would have raised approximately ₹4.75 crore. The cancellation was triggered because the proposed allottee failed to transfer the required share application money within the stipulated timeline. This follows the company receiving in-principle approvals from the NSE and BSE as recently as April 16, 2026.
Key Highlights
Withdrawal of preferential issue for 2,90,000 equity shares at ₹164 per share.
The total value of the cancelled fundraise was approximately ₹4.75 crore.
Cancellation caused by the allottee's failure to remit funds within the required timeframe.
Board passed a circular resolution on May 1, 2026, to formally cancel the private placement.
👀 What to Watch
Investors should note the failure of this specific fundraise and monitor if the company seeks alternative capital sources for its operations. While the amount is relatively small, the inability of the allottee to complete the transaction may reflect a minor execution hurdle.
